Table 1 Clinical characteristics of patients with irritable bowel syndrome (IBS) and Healthy Volunteers (HV).

From: Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS)

Data show mean (standard deviation [SD]) except where specified

HV

(n = 17)

IBS-C

(n = 15)

IBS- D

(n = 26)

Age (years)

31.7 (13.6)

34.3 (10.5)

38.7 (15.3)

Women, n (%)

12 (71%)

13 (87%)

18 (70%)

BMI, kg/m2

26.3 (5.9)

25.3 (5.2)

26.7 (9.4)

White, n (%)

9 (53%)

10 (67%)

23 (88%)

Baseline dietary intake*

   

Energy (kcal)

1946.8 (1025.7)

2028.4 (1717.3)

1514.1 (557.4)

Total carbohydrates (g)

219.4 (155.6)

191.1 (153.7)

160.1 (62.9)

Starch (g)

104.7 (54.9)

107.9 (110.9)

87.7 (46.9)

Protein (g)

100.9 (47.1)

96.8 (75.3)

75.1 (23.4)

Fat (g)

77.6 (34.7)

99.6 (101.9)

63.8 (30.3)

Fiber (g)

17.9 (20.9)

14.3 (10.0)

11.6 (4.1)

  1. Group comparisons were conducted using the ANOVA F- and Fisher exact tests. IBS-C, IBS with constipation; IBS-D, IBS with diarrhea; *Diet data missing for two participants with IBS-C and four participants with IBS-D.
Back to article page